Compounds > tiletamine hydrochloride
Page last updated: 2024-08-22

tiletamine hydrochloride and Cryopyrin-Associated Periodic Syndromes

tiletamine hydrochloride has been researched along with Cryopyrin-Associated Periodic Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, S; Koike, R; Komatsu, S; Kubota, T; Miyasaka, N; Shimogaki, S; Umezawa, K1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Cryopyrin-Associated Periodic Syndromes

ArticleYear
Inhibition of the NF-κB pathway as a candidate therapeutic strategy for cryopyrin-associated periodic syndrome.
    Modern rheumatology, 2014, Volume: 24, Issue:3

    Topics: Benzamides; Cryopyrin-Associated Periodic Syndromes; Cyclohexanones; Cytokines; Human Umbilical Vein Endothelial Cells; Humans; Leukocytes, Mononuclear; NF-kappa B; Signal Transduction

2014